Literature DB >> 16407641

Bioavailability of apigenin from apiin-rich parsley in humans.

Hellen Meyer1, Adrian Bolarinwa, Guenther Wolfram, Jakob Linseisen.   

Abstract

AIM: Absorption and excretion of apigenin after the ingestion of apiin-rich food, i.e. parsley, was tested.
METHODS: Eleven healthy subjects (5 women, 6 men) in the age range of 23-41 years and with an average body mass index of 23.9 +/- 4.1 kg/m2 took part in this study. After an apigenin- and luteolin-free diet, a single oral bolus of 2 g blanched parsley (corresponding to 65.8 +/- 15.5 micromol apigenin) per kilogram body weight was consumed. Blood samples were taken at 0, 4, 6, 7, 8, 9, 10, 11 and 28 h after parsley consumption and 24-hour urine samples were collected. Apigenin was analyzed in plasma, urine and red blood cells by means of HPLC-ECD.
RESULTS: On average, a maximum apigenin plasma concentration of 127 +/- 81 nmol/l was reached after 7.2 +/- 1.3 h with a high range of variation between subjects. For all participants, plasma apigenin concentration rose after bolus ingestion and fell within 28 h under the detection limit (2.3 nmol/l). The average apigenin content in 24-hour urine was 144 +/- 110 nmol/24 h corresponding to 0.22 +/- 0.16% of the ingested dose. The flavone could be detected in red blood cells without showing dose-response characteristics.
CONCLUSIONS: A small portion of apigenin provided by food reaches the human circulation and, therefore, may reveal biological effects. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407641     DOI: 10.1159/000090736

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  38 in total

1.  Enzymatic synthesis of apigenin glucosides by glucosyltransferase (YjiC) from Bacillus licheniformis DSM 13.

Authors:  Rit Bahadur Gurung; Eun-Hee Kim; Tae-Jin Oh; Jae Kyung Sohng
Journal:  Mol Cells       Date:  2013-10-22       Impact factor: 5.034

Review 2.  Flavones: Food Sources, Bioavailability, Metabolism, and Bioactivity.

Authors:  Gregory L Hostetler; Robin A Ralston; Steven J Schwartz
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

3.  Correctors and Potentiators Rescue Function of the Truncated W1282X-Cystic Fibrosis Transmembrane Regulator (CFTR) Translation Product.

Authors:  Peter M Haggie; Puay-Wah Phuan; Joseph-Anthony Tan; Haijin Xu; Radu G Avramescu; Doranda Perdomo; Lorna Zlock; Dennis W Nielson; Walter E Finkbeiner; Gergely L Lukacs; Alan S Verkman
Journal:  J Biol Chem       Date:  2016-11-28       Impact factor: 5.157

4.  Mucin 1 C-terminal subunit oncoprotein is a target for small-molecule inhibitors.

Authors:  Yongchun Zhou; Hasan Rajabi; Donald Kufe
Journal:  Mol Pharmacol       Date:  2011-02-23       Impact factor: 4.436

Review 5.  Insights into dietary flavonoids as molecular templates for the design of anti-platelet drugs.

Authors:  Bernice Wright; Jeremy P E Spencer; Julie A Lovegrove; Jonathan M Gibbins
Journal:  Cardiovasc Res       Date:  2012-09-27       Impact factor: 10.787

6.  A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids.

Authors:  Bernice Wright; Leonardo A Moraes; Charles F Kemp; William Mullen; Alan Crozier; Julie A Lovegrove; Jonathan M Gibbins
Journal:  Br J Pharmacol       Date:  2010-02-10       Impact factor: 8.739

7.  Effects of food formulation and thermal processing on flavones in celery and chamomile.

Authors:  Gregory L Hostetler; Ken M Riedl; Steven J Schwartz
Journal:  Food Chem       Date:  2013-04-25       Impact factor: 7.514

Review 8.  Phytochemicals for the Management of Melanoma.

Authors:  Harish Chandra Pal; Katherine Marchiony Hunt; Ariana Diamond; Craig A Elmets; Farrukh Afaq
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

9.  The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells.

Authors:  Emilie C Lefort; Jonathan Blay
Journal:  Clin Exp Metastasis       Date:  2011-02-05       Impact factor: 5.150

10.  Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.

Authors:  Sanjeev Shukla; Natarajan Bhaskaran; Melissa A Babcook; Pingfu Fu; Gregory T Maclennan; Sanjay Gupta
Journal:  Carcinogenesis       Date:  2013-09-25       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.